Resources

Cannabis-based products for medical use in humans

The UK regulatory agency, MHRA, has published a guidance on the supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use in humans.

Read more
UK CBPM

Clinical pharmacology in dermatology drug development

Pharmacokinetic Considerations for Topical Medications

Read more

Project Optimus in oncology drug development

It is now a requirement for all sponsors to implement Project Optimus into their oncology drug development programs for dose optimisation.

Read more